Benefits for Physicians

RTsafe’s innovative technology brings you confidence and control across the entire treatment process. Confirmation of prescribed doses in a simulated environment verifies the efficacy of your plans ahead of treatment execution. As a result, even your most demanding cases (such as multiple brain metastases) can be carried out with more confidence and reliability.

Your ability to visualize a patient’s treatment through individualized simulation ensures the desired outcome while simultaneously minimizing the possibility of debilitating side effects. You have the option to share the simulation with the patient, and help them to understand the whole process. In this way, you can provide exceptional patient involvement and empowerment by offering compelling evidence of safe and accurate treatment ahead of a medical intervention.

Additionally, you can store data from the simulation in each patient’s medical record as
proof of good medical practice.

product_pseudopatient

PseudoPatient®

Patient Treatment Verification Redefined. Safety Personalized.

PseudoPatient® is an FDA cleared device constructed by the real patient’s CT data using highly accurate 3D printing technology. It forms an anatomically accurate replica of patient’s head, providing physicians and medical physicists with either direct dose measurements of anatomic regions of high interest (point, 2D), or a full relative 3D dose map, ideal for demanding SRS cases, such as small benign tumors.

Publications

  • Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery

    Benedikt Thomann, Tobias Fechter, Johannes Fischer, Armin Runz, Julian Roers, Ute Ludwig, Melanie Grehn, Maximilian Grohmann, Christian Ziemann, Michael Judge, Wolfgang Baus, Michelle Grahle, Matthias Walke, Bastian Bathen, Janett Köhn, Paul Käthner, Maya Shariff, Rebecca Matthis, Jens Fleckenstein, Sascha Großmann, Tino Streller, Simon Howitz, Marlen Priegnitz, Rocco Weigel, Peter Winkler, Oliver Blanck, Daniela Schmitt, Jurgen Beck, Marcia Machein, Evangelos Pappas, Ilinca Popp, Michael Reiner, Christian P. Karger, Christos Moustakis, Michael Bock, Anca-Ligia Grosu, Dimos Baltas Strahlentherapie und Onkologie (2025)
  • Suitability of a BeO-based OSLD system for end-to-end remote dosimetry tests in SRS/SRT applications

    Alexandra Drakopoulou , Polymnia Glampedaki, Vasiliki Peppa, Efi Koutsouveli, Georgios Kollias, Pantelis Karaiskos, Eleftherios P. Pappas European Journal of Medical Physics (2025)

Request a quote

See Whats new at RTsafe

RTsafeGulf Becomes the First Company globally Licensed by Federal Authority for Nuclear Regulation to Provide Radiotherapy Medical Physics Services in the United Arab Emirates

RTsafeGulf Becomes the First Company globally Licensed by Federal Authority for Nuclear Regulation to Provide Radiotherapy Medical Physics Services in the United Arab Emirates

Announcements
Abu Dhabi, United Arab Emirates/ Athens, Greece – March 17, 2026 RTsafe announces that RTsafeGulf Limited, its regional entity based...
Read More
RTsafe’s PseudoPatient Receives Saudi FDA Authorization, Expanding Access to Advanced Radiotherapy QA Across the Kingdom

RTsafe’s PseudoPatient Receives Saudi FDA Authorization, Expanding Access to Advanced Radiotherapy QA Across the Kingdom

Announcements
Athens, Greece, February 19, 2026 RTsafe is proud to announce that its core innovation, the PseudoPatient®, has received official Medical...
Read More
RTsafe to exhibit at BRSS 10th Annual Meeting in Manchester

RTsafe to exhibit at BRSS 10th Annual Meeting in Manchester

Conferences - Tradeshows
Meet us in Manchester to learn about RTsafe’s dosimetry audit services, solutions for end-to-end quality assurance, and patient safety in...
Read More
×
«
ΕΣΠΑ Banner